Brokerages Set Tenet Healthcare Co. (NYSE:THC) Target Price at $165.00

Tenet Healthcare Co. (NYSE:THCGet Free Report) has received a consensus recommendation of “Moderate Buy” from the seventeen ratings firms that are covering the firm, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation, thirteen have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $165.00.

A number of research firms have issued reports on THC. JPMorgan Chase & Co. reaffirmed an “overweight” rating and issued a $175.00 price target on shares of Tenet Healthcare in a research report on Tuesday, December 17th. StockNews.com downgraded shares of Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, December 17th. Barclays increased their price objective on shares of Tenet Healthcare from $171.00 to $190.00 and gave the company an “overweight” rating in a research report on Friday, November 8th. UBS Group lifted their price objective on shares of Tenet Healthcare from $197.00 to $217.00 and gave the stock a “buy” rating in a research report on Wednesday, October 30th. Finally, Cantor Fitzgerald raised their price target on Tenet Healthcare from $168.00 to $177.00 and gave the company an “overweight” rating in a research note on Wednesday, October 30th.

Read Our Latest Report on Tenet Healthcare

Insider Buying and Selling

In other news, EVP Lisa Y. Foo sold 4,000 shares of the business’s stock in a transaction that occurred on Thursday, October 31st. The stock was sold at an average price of $155.94, for a total value of $623,760.00. Following the transaction, the executive vice president now owns 15,566 shares of the company’s stock, valued at approximately $2,427,362.04. The trade was a 20.44 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.93% of the stock is owned by company insiders.

Hedge Funds Weigh In On Tenet Healthcare

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Plato Investment Management Ltd purchased a new position in Tenet Healthcare in the third quarter worth $28,000. ORG Wealth Partners LLC purchased a new stake in Tenet Healthcare during the third quarter worth about $30,000. Financial Management Professionals Inc. increased its holdings in Tenet Healthcare by 2,222.2% in the third quarter. Financial Management Professionals Inc. now owns 209 shares of the company’s stock valued at $35,000 after buying an additional 200 shares in the last quarter. True Wealth Design LLC acquired a new stake in shares of Tenet Healthcare during the 3rd quarter valued at approximately $38,000. Finally, Kayne Anderson Rudnick Investment Management LLC acquired a new stake in shares of Tenet Healthcare in the 2nd quarter worth approximately $34,000. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

Tenet Healthcare Stock Up 2.8 %

Shares of NYSE:THC opened at $134.56 on Friday. The firm’s 50-day moving average is $136.39 and its two-hundred day moving average is $148.10. The company has a debt-to-equity ratio of 2.35, a current ratio of 1.58 and a quick ratio of 1.52. Tenet Healthcare has a 1 year low of $79.00 and a 1 year high of $171.20. The firm has a market capitalization of $12.80 billion, a PE ratio of 4.31, a price-to-earnings-growth ratio of 0.59 and a beta of 2.06.

Tenet Healthcare (NYSE:THCGet Free Report) last released its earnings results on Tuesday, October 29th. The company reported $2.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.33 by $0.60. Tenet Healthcare had a net margin of 14.91% and a return on equity of 24.05%. The company had revenue of $5.12 billion for the quarter, compared to analyst estimates of $5.05 billion. During the same period in the prior year, the business earned $1.44 EPS. The firm’s quarterly revenue was up 1.1% on a year-over-year basis. Analysts predict that Tenet Healthcare will post 11.37 EPS for the current year.

Tenet Healthcare Company Profile

(Get Free Report

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

Featured Stories

Analyst Recommendations for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.